Associations of pregnancy‐related factors and birth characteristics with risk of endometrial cancer: A Nordic population‐based case–control study. Issue 6 (20th June 2019)

• Record Type: Journal Article
• Authors: Trabert, Britton; Troisi, Rebecca; Grotmol, Tom; Ekbom, Anders; Engeland, Anders; Gissler, Mika; Glimelius, Ingrid; Madanat‐Harjuoja, Laura; Sørensen, Henrik Toft; Tretli, Steinar; Gulbech Ording, Anne; Bjørge, Tone
• Is Part Of: International journal of cancer. Volume 146:Issue 6(2020)
• Page Start: 1523
• Page End: 1531
• Publication Date: 2019-06-20
• Subjects: endometrial cancer -- Nordic countries -- pregnancy timing -- preeclampsia -- hypertension; Cancer -- Periodicals; Cancer -- Prevention -- Periodicals; 616.994
• DOI: 10.1002/ijc.32494
• Languages: English
• ISSNs: 0020-7136

Abstract

Abstract : Many pregnancy‐related factors are associated with reduced endometrial cancer risk. However, it remains unclear whether pregnancy‐related complications (e.g., hypertensive conditions) are associated with risk and whether these associations vary by endometrial cancer subtype. Thus, we evaluated the risk of endometrial cancer, overall and by subtype, in relation to pregnancy‐related factors, pregnancy complications and birth characteristics. Utilizing population‐based register data from four Nordic countries, we conducted a nested case–control analysis of endometrial cancer risk. We included 10, 924 endometrial cancer cases and up to 10 matched controls per case. Odds ratios (ORs) with 95% confidence intervals (CIs) were derived from unconditional logistic regression models. We further evaluated associations by individual histology (i.e., endometrioid, serous, etc.) or, for rare exposures (e.g., pregnancy complications), by dualistic type (Type I [ n = 10, 343] and Type II [ n = 581]). Preexisting and pregnancy‐related hypertensive conditions were associated with increased endometrial cancer risk (OR [95% CI]: preexisting hypertension 1.88 [1.39–2.55]; gestational hypertension 1.47 [1.33–1.63]; preeclampsia 1.43 [1.30–1.58]), with consistent associations across dualistic type. Increasing number of pregnancies (≥4 vs . 1 birth: 0.64 [0.59–0.69]) and shorter time since last birth (<10 vs . ≥30 years: 0.34 [0.29–0.40]) were associated with reduced endometrial cancer risk, with consistent associations across most subtypes. Our findings support the role for both hormonal exposures and cell clearance as well as immunologic/inflammatory etiologies for endometrial cancer. This research supports studying endometrial hyperplasia, a precursor condition of endometrial cancer, in the context of pregnancy‐related exposures, as this may provide insight into the mechanisms by which pregnancy affects subsequent cancer risk. Abstract : What's new? Many pregnancy‐related factors are associated with reduced endometrial‐cancer risk. Are pregnancy‐related complications also associated with altered risk? In study, the authors found that pre‐existing and gestational hypertension, as well as preeclampsia, were associated with an increased risk of endometrial cancer, suggesting that immunologic and/or inflammatory etiologies may be relevant in endometrial carcinogenesis. They also conclude that the reduced risk associated with higher parity and later age at birth also suggest an important role for hormonal and cell‐clearance mechanisms. These results support further study of how endometrial hyperplasia, a precursor of endometrial cancer, in the context of pregnancy‐related exposures influences cancer risk.